Sinil Pharmaceutical Co. Ltd (012790) - Total Liabilities

Latest as of September 2025: ₩18.23 Billion KRW ≈ $12.35 Million USD

Based on the latest financial reports, Sinil Pharmaceutical Co. Ltd (012790) has total liabilities worth ₩18.23 Billion KRW (≈ $12.35 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sinil Pharmaceutical Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Sinil Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Sinil Pharmaceutical Co. Ltd to evaluate short-term liquidity relative to the company's equity base.

Sinil Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Sinil Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Nanoveu Ltd AU:NVU	Australia	AU$1.46 Million
Chian Hsing Forging Industrial Co Ltd TWO:4528	Taiwan	NT$1.46 Billion
Obase Bilgisayar ve Danismanlik Hizmetleri Ticaret A.S. IS:OBASE	Turkey	TL322.75 Million
Zenith Minerals Ltd AU:ZNC	Australia	AU$974.40K
Goodyear (Thailand) Public Company Limited BK:GYT	Thailand	฿5.19 Billion
Kedawung Setia Industrial Tbk JK:KDSI	Indonesia	Rp490.81 Billion
Comunication Weaver Co.Ltd KQ:056360	Korea	₩24.66 Billion
Atlantic International Corp. Common Stock NASDAQ:ATLN	USA	$145.32 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Sinil Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 012790 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sinil Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sinil Pharmaceutical Co. Ltd (2014–2024)

The table below shows the annual total liabilities of Sinil Pharmaceutical Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩19.36 Billion ≈ $13.12 Million	+10.20%
2023-12-31	₩17.56 Billion ≈ $11.90 Million	-10.18%
2022-12-31	₩19.55 Billion ≈ $13.25 Million	+23.94%
2021-12-31	₩15.78 Billion ≈ $10.69 Million	-8.94%
2020-12-31	₩17.33 Billion ≈ $11.74 Million	+4.42%
2019-12-31	₩16.59 Billion ≈ $11.24 Million	+47.90%
2018-12-31	₩11.22 Billion ≈ $7.60 Million	-3.20%
2017-12-31	₩11.59 Billion ≈ $7.85 Million	+6.69%
2016-12-31	₩10.86 Billion ≈ $7.36 Million	+19.49%
2015-12-31	₩9.09 Billion ≈ $6.16 Million	+0.39%
2014-12-31	₩9.06 Billion ≈ $6.14 Million	--

About Sinil Pharmaceutical Co. Ltd

KQ:012790 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$41.99 Million

₩61.96 Billion KRW

Market Cap Rank

#22603 Global

#1445 in Korea

Share Price

₩5360.00

Change (1 day)

-1.11%

52-Week Range

₩5000.00 - ₩6920.00

All Time High

₩50717.45